132 related articles for article (PubMed ID: 34554213)
1. Flavin oxidation state impacts on nitrofuran antibiotic binding orientation in nitroreductases.
Toogood HS; Scrutton NS
Biochem J; 2021 Sep; 478(18):3423-3428. PubMed ID: 34554213
[TBL] [Abstract][Full Text] [Related]
2. The structures of E. coli NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN.
Day MA; Jarrom D; Christofferson AJ; Graziano AE; Anderson JLR; Searle PF; Hyde EI; White SA
Biochem J; 2021 Jul; 478(13):2601-2617. PubMed ID: 34142705
[TBL] [Abstract][Full Text] [Related]
3. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
[TBL] [Abstract][Full Text] [Related]
4. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate.
Day MA; Jarrom D; Rajah N; Searle PF; Hyde EI; White SA
Proteins; 2023 May; 91(5):585-592. PubMed ID: 36443029
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the transformation of the traditional medicine berberine by bacterial nitroreductase.
Wen HY; Pan LB; Ma SR; Yang XY; Hu JC; Zhao HF; Gao ZQ; Dong YH; Wang Y; Zhang H
Acta Crystallogr D Struct Biol; 2022 Oct; 78(Pt 10):1273-1282. PubMed ID: 36189746
[TBL] [Abstract][Full Text] [Related]
7. Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme.
Race PR; Lovering AL; Green RM; Ossor A; White SA; Searle PF; Wrighton CJ; Hyde EI
J Biol Chem; 2005 Apr; 280(14):13256-64. PubMed ID: 15684426
[TBL] [Abstract][Full Text] [Related]
8. The 3D-structure, kinetics and dynamics of the E. coli nitroreductase NfsA with NADP
White SA; Christofferson AJ; Grainger AI; Day MA; Jarrom D; Graziano AE; Searle PF; Hyde EI
FEBS Lett; 2022 Sep; 596(18):2425-2440. PubMed ID: 35648111
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of major Escherichia coli reductases involved in aerobic nitro and azo reduction.
Mercier C; Chalansonnet V; Orenga S; Gilbert C
J Appl Microbiol; 2013 Oct; 115(4):1012-22. PubMed ID: 23795903
[TBL] [Abstract][Full Text] [Related]
10. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
[TBL] [Abstract][Full Text] [Related]
11. Study of the role played by NfsA, NfsB nitroreductase and NemA flavin reductase from Escherichia coli in the conversion of ethyl 2-(2'-nitrophenoxy)acetate to 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (D-DIBOA), a benzohydroxamic acid with interesting biological properties.
Valle A; Le Borgne S; Bolívar J; Cabrera G; Cantero D
Appl Microbiol Biotechnol; 2012 Apr; 94(1):163-71. PubMed ID: 22173483
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824.
Kutty R; Bennett GN
Arch Microbiol; 2005 Nov; 184(3):158-67. PubMed ID: 16187099
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase.
Zenno S; Koike H; Kumar AN; Jayaraman R; Tanokura M; Saigo K
J Bacteriol; 1996 Aug; 178(15):4508-14. PubMed ID: 8755878
[TBL] [Abstract][Full Text] [Related]
14. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Johansson E; Parkinson GN; Denny WA; Neidle S
J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
[TBL] [Abstract][Full Text] [Related]
15. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.
Sisson G; Goodwin A; Raudonikiene A; Hughes NJ; Mukhopadhyay AK; Berg DE; Hoffman PS
Antimicrob Agents Chemother; 2002 Jul; 46(7):2116-23. PubMed ID: 12069963
[TBL] [Abstract][Full Text] [Related]
16. Oxygen-insensitive nitroreductases of Escherichia coli do not reduce 3-nitrotyrosine.
Lightfoot RT; Shuman D; Ischiropoulos H
Free Radic Biol Med; 2000 Apr; 28(7):1132-6. PubMed ID: 10832075
[TBL] [Abstract][Full Text] [Related]
17. E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.
Vass SO; Jarrom D; Wilson WR; Hyde EI; Searle PF
Br J Cancer; 2009 Jun; 100(12):1903-11. PubMed ID: 19455141
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
García V; Montero I; Bances M; Rodicio R; Rodicio MR
Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of chromate reduction by the Escherichia coli protein, NfsA, and the role of different chromate reductases in minimizing oxidative stress during chromate reduction.
Ackerley DF; Gonzalez CF; Keyhan M; Blake R; Matin A
Environ Microbiol; 2004 Aug; 6(8):851-60. PubMed ID: 15250887
[TBL] [Abstract][Full Text] [Related]
20. Type I nitroreductases of Escherichia coli.
Bryant DW; McCalla DR; Leeksma M; Laneuville P
Can J Microbiol; 1981 Jan; 27(1):81-6. PubMed ID: 7011517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
